148 related articles for article (PubMed ID: 14592885)
21. [Morphology of the thymus gland in children with myasthenia gravis].
Kop'eva TN; Sekamova SM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):13-7. PubMed ID: 2176031
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
23. Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells.
Jakubíková M; Piťha J; Marečková H; Týblová M; Nováková I; Schutzner J
J Neurol Sci; 2015 Nov; 358(1-2):101-6. PubMed ID: 26320610
[TBL] [Abstract][Full Text] [Related]
24. Up-regulated expression of Fas antigen in peripheral T cell subsets in patients with myasthenia gravis.
Mai W; Liu X; Fan Y; Liu H; Hong HY; Han R; Zhou W
Clin Invest Med; 2012 Oct; 35(5):E294. PubMed ID: 23043710
[TBL] [Abstract][Full Text] [Related]
25. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
26. Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus.
Chen Z; Luo H; Peng Y; Cai L; Zhang J; Su C; Zou J
Ann Thorac Surg; 2011 Jan; 91(1):212-8. PubMed ID: 21172515
[TBL] [Abstract][Full Text] [Related]
27. [Myasthenia gravis: epithelial cells of the hyperplastic thymus. Morphometric and ultrastructural study].
Répássy G; Szobor A; Lapis K; Szathmáry I
Morphol Igazsagugyi Orv Sz; 1979 Jul; 19(3):199-204. PubMed ID: 503091
[TBL] [Abstract][Full Text] [Related]
28. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
29. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy.
Alpert LI; Papatestas A; Kark A; Osserman RS; Osserman K
Arch Pathol; 1971 Jan; 91(1):55-61. PubMed ID: 4922629
[No Abstract] [Full Text] [Related]
30. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
[TBL] [Abstract][Full Text] [Related]
31. Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis.
Utsugisawa K; Nagane Y; Tohgi H
Muscle Nerve; 2000 Apr; 23(4):507-13. PubMed ID: 10716760
[TBL] [Abstract][Full Text] [Related]
32. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression.
Kawahata K; Misaki Y; Yamauchi M; Tsunekawa S; Setoguchi K; Miyazaki J; Yamamoto K
J Immunol; 2002 May; 168(9):4399-405. PubMed ID: 11970982
[TBL] [Abstract][Full Text] [Related]
33. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
[TBL] [Abstract][Full Text] [Related]
34. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
Melms A; Malcherek G; Gern U; Sommer N; Weissert R; Wiethölter H; Bühring HJ
J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):46-51. PubMed ID: 8094093
[TBL] [Abstract][Full Text] [Related]
35. [Histological picture of the thymus in relation to the result of thymectomy in myasthenia gravis].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1974 Jun; 118(23):896. PubMed ID: 4839445
[No Abstract] [Full Text] [Related]
36. Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients.
Huang S; Wang W; Chi L
BMC Neurol; 2015 Sep; 15():163. PubMed ID: 26347149
[TBL] [Abstract][Full Text] [Related]
37. Thymus, thymoma, and specific T cells in myasthenia gravis.
Beeson D; Bond AP; Corlett L; Curnow SJ; Hill ME; Jacobson LW; MacLennan C; Meager A; Moody AM; Moss P; Nagvekar N; Newsom-Davis J; Pantic N; Roxanis I; Spack EG; Vincent A; Willcox N
Ann N Y Acad Sci; 1998 May; 841():371-87. PubMed ID: 9668262
[No Abstract] [Full Text] [Related]
38. [Changes in the thymus gland in myasthenia gravis].
Strukov AI; Gornak KA; Kop'eva TN
Vestn Akad Med Nauk SSSR; 1968; 23(12):68-74. PubMed ID: 5744507
[No Abstract] [Full Text] [Related]
39. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
[TBL] [Abstract][Full Text] [Related]
40. Thymectomy and systemic lupus erythematosus (SLE).
Panarese A; D'Andrea V; Pironi D; Filippini A
Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
